Department of Hepato-Biliary Pancreatic Surgery, Zhongnan Hospital of Wuhan University, East lake Road 169, Wuhan, 430070, Hubei, People's Republic of China.
Surg Endosc. 2020 Jun;34(6):2483-2489. doi: 10.1007/s00464-019-07051-y. Epub 2019 Aug 19.
There are a variety of strategies for the treatment of patients with cholecysto-choledocholithiasis (CCL). Although the surgical approach of choice is preoperative ERCP and laparoscopic cholecystectomy (ERCP + LC), controversy remains regarding which procedure is optimal for CCL.
To evaluate the safety and effectiveness of laparoendoscopic rendezvous (LERV) versus ERCP + LC for CCL, a total of 528 patients with CCL were retrospectively studied from January 2013 to December 2018. The patients were scheduled to undergo either the LERV or ERCP + LC procedure. The LERV group included 123 cases, whereas the ERCP + LC group contained 137 cases. The incidence of postoperative complications, success of stone clearance, length of hospital stay, and hospitalization charges were statistically analyzed.
The incidence of pancreatitis was lower in the LERV group than in the ERCP + LC group (3/123 vs. 12/137, P = 0.0291). The median level of post-ERCP amylase was much lower in the LERV group (202.5 U/dL vs. 328.1 U/dL, P < 0.01). However, there was no significant difference in the stone clearance rate or other early complications between the two groups. Further study showed that the length of hospital stay and cost in the LERV group were less than those in the ERCP + LC group (12 days vs. 18 days, P < 0.01; 53591.4¥ vs. 60089.2¥, P < 0.01). In addition, more patients in the two-stage procedure group experienced later biliary complications compared with those in the one-stage approach group (34/137 vs. 4/123, P < 0.05). However, the median operation time was 107.7 min in the two-stage group and 139.8 min in the one-stage group (P < 0.05).
The LERV technique is a safe and effective approach for CCL with lower pancreatitis; it was associated with few later biliary complications, shortened hospital stays, and fewer charges but significantly longer operative time.
对于胆石性胆-胆管结石(CCL)患者,有多种治疗策略。尽管术前内镜逆行胰胆管造影(ERCP)和腹腔镜胆囊切除术(ERCP+LC)是首选的手术方法,但对于 CCL 哪种方法最佳仍存在争议。
为了评估腹腔镜内镜联合(LERV)与 ERCP+LC 治疗 CCL 的安全性和有效性,我们回顾性研究了 2013 年 1 月至 2018 年 12 月期间 528 例 CCL 患者。这些患者被安排接受 LERV 或 ERCP+LC 手术。LERV 组包括 123 例,而 ERCP+LC 组包括 137 例。对术后并发症发生率、结石清除成功率、住院时间和住院费用进行了统计学分析。
LERV 组胰腺炎的发生率低于 ERCP+LC 组(3/123 比 12/137,P=0.0291)。LERV 组术后 ERCP 淀粉酶水平中位数较低(202.5 U/dL 比 328.1 U/dL,P<0.01)。然而,两组之间的结石清除率或其他早期并发症无显著差异。进一步研究表明,LERV 组的住院时间和费用均少于 ERCP+LC 组(12 天比 18 天,P<0.01;53591.4¥比 60089.2¥,P<0.01)。此外,与一期治疗组相比,两阶段治疗组中有更多的患者发生后期胆道并发症(34/137 比 4/123,P<0.05)。然而,两阶段组的中位手术时间为 107.7 分钟,而一期组为 139.8 分钟(P<0.05)。
LERV 技术是一种安全有效的治疗 CCL 的方法,其胰腺炎发生率较低,且术后胆道并发症较少,住院时间较短,费用较低,但手术时间明显较长。